Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study

被引:0
|
作者
Di Rienzo, Valerio [1 ]
Cadario, Gianni [2 ]
Grieco, Teresa [3 ]
Galluccio, Antonia G. [4 ]
Caffarelli, Carlo [5 ]
Liotta, Giuseppe [6 ]
Pecora, Silvia [7 ]
Burastero, Samuele E. [7 ,8 ]
机构
[1] USL Frosinone, Frosinone, Italy
[2] Azienda Osped S Giovanni Battista Torino, SC Allergol Immunol Clin, Turin, Italy
[3] Policlin Umberto 1, Dipartimento Malattie Cutanee & Veneree Chirurg P, Rome, Italy
[4] Osped S Cuore di Gesu Fatebenefratelli, UO Dermatol & Venereol, Benevento, Italy
[5] Clin Pediat, Parma, Italy
[6] CNR, IBIM, Palermo, Italy
[7] ALK Abello Italy, Milan, Italy
[8] Ist Sci San Raffaele, I-20132 Milan, Italy
关键词
ALLERGIC RHINITIS; METAANALYSIS; EFFICACY; TRIALS; ASTHMA; AGE;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:671 / +
页数:4
相关论文
共 50 条
  • [41] A randomized, assessor-blind, parallel-group, multicentre, phase IV comparative trial of a suffocant compared with malathion in the treatment of head lice in children
    Greive, Kerryn A.
    Lui, Ada H.
    Barnes, Tanya M.
    Oppenheim, V. M. Jane
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2010, 51 (03) : 175 - 182
  • [42] Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study
    Pajno, GB
    Morabito, L
    Barberio, G
    Parmiani, S
    ALLERGY, 2000, 55 (09) : 842 - 849
  • [43] Single-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites Alone and in Combination with Gemfibrozil, Itraconazole, or Rifampin in Healthy Subjects: A Randomized, Parallel-Group, Open-Label Study
    Tran, Jonathan Q.
    Zhang, Peijin
    Ghosh, Atalanta
    Liu, Liangang
    Syto, Mary
    Wang, Xiaomin
    Palmisano, Maria
    ADVANCES IN THERAPY, 2020, 37 (10) : 4381 - 4395
  • [44] The safety and tolerability of a one strength dose-escalation scheme for subcutaneous immunotherapy with a native house dust mite extract in Chinese children: A multicenter, randomized, open label clinical trial
    Zhi, Lili
    Bai, Yan
    Liao, Wang
    Chen, Guohua
    Gao, Tingting
    Wan, Xia
    Liang, Jiawen
    Liu, Lingling
    Chen, Liang
    Zhang, Wenna
    Bai, Jun
    HELIYON, 2024, 10 (08)
  • [45] A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis of children with asthma
    Philippe Bareille
    Susan Tomkins
    Varsha Imber
    Mohammed Tayob
    Karen Dunn
    Rashmi Mehta
    Sanjeev Khindri
    Allergy, Asthma & Clinical Immunology, 16
  • [46] Comparison of Polyethylene Glycol with and without Electrolytes in the Treatment of Constipation in Elderly Institutionalized Patients A Randomized, Double-Blind, Parallel-Group Study
    Seinela, Lauri
    Sairanen, Ulla
    Laine, Tarmo
    Kurl, Sangita
    Pettersson, Tiina
    Happonen, Pertti
    DRUGS & AGING, 2009, 26 (08) : 703 - 713
  • [47] A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
    Collin, C.
    Ehler, E.
    Waberzinek, G.
    Alsindi, Z.
    Davies, P.
    Powell, K.
    Notcutt, W.
    O'Leary, C.
    Ratcliffe, S.
    Novakova, I.
    Zapletalova, O.
    Pikova, J.
    Ambler, Z.
    NEUROLOGICAL RESEARCH, 2010, 32 (05) : 451 - 459
  • [48] Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study
    Budimirovic, Dejan B.
    Dominick, Kelli C.
    Gabis, Lidia, V
    Adams, Maxwell
    Adera, Mathews
    Huang, Linda
    Ventola, Pamela
    Tartaglia, Nicole R.
    Berry-Kravis, Elizabeth
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial
    Mori, Masaaki
    Hara, Takuma
    Kikuchi, Masako
    Shimizu, Hiroyuki
    Miyamoto, Tomoyuki
    Iwashima, Satoru
    Oonishi, Tatsuya
    Hashimoto, Kunio
    Kobayashi, Norimoto
    Waki, Kenji
    Suzuki, Yasuo
    Otsubo, Yoshikazu
    Yamada, Hiroshi
    Ishikawa, Chikao
    Kato, Taichi
    Fuse, Shigeto
    SCIENTIFIC REPORTS, 2018, 8
  • [50] A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic-pituitary-adrenocortical axis of children with asthma
    Bareille, Philippe
    Tomkins, Susan
    Imber, Varsha
    Tayob, Mohammed
    Dunn, Karen
    Mehta, Rashmi
    Khindri, Sanjeev
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):